Concepedia

Gary Albert

GA

Statistics

Publications

17

Citations

3K

H-Index

16

Active since

1974

Affiliations

Novavax (United States)(Current)

South African Medical Research Council

University of Maryland, Baltimore

University of Pretoria

Centre for the AIDS Programme of Research in South Africa

Gary Albert is an author at Novavax (United States) specializing in medicine, immunology, and vaccine development.

ORCID

Top concepts

Publications per year

1974–2023

17

Publications

17

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gary Albert, Iksung Cho et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 652 citations · Full text

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

Martin R. Zamora, Marie Budev, Mark W. Rolfe et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 204 citations

Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer

Christian Manegold, Donald Gravenor, Donald Woytowitz et al. · Journal of Clinical Oncology · 2008 · 167 citations · Full text

Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial

Neil Formica, Raburn M. Mallory, Gary Albert et al. · PLoS Medicine · 2021 · 112 citations · Full text

1–5 of 17